Functional studies on platelet adhesion with recombinant von Willebrand factor type 2b mutants R543Q and R543W under conditions of flow

Blood

Volumn 89, Issue 8, 1997, Pages 2766-2772

  Lankhof, Hanneke ^a   Damas, Conchi ^a   Schiphorst, Marion E ^a   IJsseldijk, Martin J W ^a   Bracke, Madelon ^a   Sixma, Jan J ^a   Vink, Tom ^a   De Groot, Philip G ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; GLYCOPROTEIN IB; HEPARIN; MUTANT PROTEIN; THROMBOCYTE RECEPTOR; TRYPTOPHAN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING; CONTROLLED STUDY; HAMSTER; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE;

EID: 0030945007     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2766     Document Type: Article

References (35)

1. Sakariassen KS, Bolhuis PA, Sixma JJ: Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279:636, 1979
2. Howard MA, Firkin BG: Ristocetin - A new tool in the investigation of platelet aggregation. Thromb Haemost 26:362, 1971
3. Read MS, Smith SV, Lamb MA, Brinkhous KM: Role of botrocetin in platelet agglutination: Formation of an activated complex of botrocetin and von Willebrand factor. Blood 74:1031, 1989
4. Roth GJ: Developing relationships: Arterial platelet adhesion, glycoprotein lb, and leucine-rich glycoproteins. Blood 77:5, 1991
5. Ginsburg D, Bowie EJ: Molecular genetics of von Willebrand disease. Blood 79:2507, 1992
6. Ginsburg D, Sadler JE: Von Willebrand disease: A database of point mutations, insertions, and deletions. Thromb Haemost 69:177, 1993
7. De Groot PG, Federici AB, de Boer HC, D'Alessio P, Mannucci PM, Sixma JJ: von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets. Proc Natl Acad Sci USA 86:3793, 1989
8. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK: Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein lb-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 31:11144, 1992
9. Sobel M, Soler DF, Kermode JC, Harris RB: Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 267:8857, 1992
10. Christophe O, Obert B, Meyer D, Girma J-P: The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein lb, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673. Blood 78:2310, 1991
11. Hilbert L, Gaucher C, De Romeuf C, Horellou MH, Vink T, Mazurier C: Leu 697 → Val mutation in mature von Willebrand factor is responsible for type IIb von Willebrand disease. Blood 83:1542, 1994
12. Randi AM, Jorieux S, Tuley EA, Mazurier C, Sadler JE: Recombinant von Willebrand factor Arg578 → Gln. A type IIb von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin. J Biol Chem 267:21187, 1992
13. Kroner PA, Kluessendorf ML, Scott JP, Montgomery RR: Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets. Blood 79:2048, 1992
14. Cooney KA, Lyons SE, Ginsburg D: Functional analysis of a type IIB von Willebrand disease missense mutation: Increased binding of large von Willebrand factor multimers to platelets. Proc Natl Acad Sci USA 89:2869, 1992
15. Ribba A-S, Voorberg J, Meyer D, Pannekoek H, Pietu G: Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease. J Biol Chem 267:23209, 1992
16. Rabinowitz I, Randi AM, Shindler KS, Tuley EA, Rustagi PK, Sadler JE: Type IIB mutation His-505 → Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem 268:20497, 1993
17. Inbal A, Kornbrot N, Harrison P, Randi AM, Sadler JE: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding - studies with recombinant von Willebrand factor. Thromb Haemost 70:1058, 1993
18. Ribba A-S, Christophe O, Derlon A, Cherel G, Siguret V, Lavergne JM, Girma J-P, Meyer D, Pietu G: Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease. Blood 83:833, 1994
19. Lankhof H, Wu Y-P, Vink T, Schiphorst ME, Zerwes H-G, De Groot PG, Sixma JJ: Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. Blood 86:1035, 1995
20. Higuchi R: Recombinant PCR, in Innis MA, Gelfand DH, Shinsky JJ, White TJ (eds): PCR protocols - A Guide to Methods and Applications. San Diego, CA, Academic, 1990
21. Voorberg J, Fontijn R, van Mourik JA, Pannekoek H: Domains involved in multimer assembly of von Willebrand Factor (vWF): Multimerization is independent of dimerization: EMBO J 9:797, 1990
22. Graham F, van der Eb A: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456, 1973
23. van Duijnhoven HLP, Creemers JWM, Kranenborg MGC, Timmer EDJ, Groeneveld A, Van den Ouweland AMW, Roebroek AJM, van de Ven WJM: Development and characterization of a panel of monoclonal antibodies against the novel subtilisin-like proprotein processing enzyme furin. Hybridoma 11:71, 1993
24. Sixma JJ, Schiphorst ME, Verweij CL, Pannekoek H: Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur J Biochem 196:369, 1991
25. Sakariassen KS, Aarts PAMM, De Groot PG, Houdijk WPM, Sixma JJ: A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 102:522, 1983
26. Van Zanten GH, Saelman EUM, Schut-Hese KM, Wu Y-P, Slootweg PJ, Nieuwenhuis HK, De Groot PG, Sixma JJ: Platelet adhesion to collagen type IV under flow conditions. Blood 88:3862, 1996
27. Federici AB, Bader R, Pagani S, Colibretti ML, De Marco L, Mannucci PM: Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: Affinity is related to multimeric size. Br J Haematol 73:93, 1989
28. De Romeuf C, Mazurier C: Heparin binding assay of von Willebrand factor (vWF) in plasma milieu - evidence of the importance of the multimerization degree of vWF. Thromb Haemost 69:436, 1993
29. Lankhof H, Schiphorst ME, Vink T, Sixma JJ: Interaction of the A3 fragment of von Willebrand factor with collagen type III. Br J Haematol 87:79, 1994 (abstr)
30. Cruz MA, Yvan H, Lee JR, Wise RJ, Handin RI: Interaction of von Willebrand factor with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF A domain polypeptides. J Biol Chem 270:10822, 1995
31. Lillicrap D, Murray EW, Benford K, Blanchette VS, Rivard GE, Wensley R, Giles AR: Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease. Br J Haematol 79:612, 1991
32. Saelman EUM, Kehrel B, Hese KM, De Groot PhG, Sixma JJ, Nieuwenhuis HK: Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV. Blood 83:3240, 1994
33. Ruggeri ZM, Ware J: von Willebrand factor. FASEB J 7:308, 1993
34. 578-Gln. A type IIB-von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin. J Biol Chem 267:21187, 1992
35. Aihara M, Kimura A, Chiba Y, Yoshida Y: Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Thromb Haemost 59:485, 1988